Cargando…
Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors
BACKGROUND: Vast amounts of rapidly accumulating biological data related to cancer and a remarkable progress in the field of artificial intelligence (AI) have paved the way for precision oncology. Our recent contribution to this area of research is CancerOmicsNet, an AI-based system to predict the t...
Autores principales: | Singha, Manali, Pu, Limeng, Stanfield, Brent A., Uche, Ifeanyi K., Rider, Paul J. F., Kousoulas, Konstantin G., Ramanujam, J., Brylinski, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694576/ https://www.ncbi.nlm.nih.gov/pubmed/36434556 http://dx.doi.org/10.1186/s12885-022-10293-0 |
Ejemplares similares
-
Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in Cancer
por: Singha, Manali, et al.
Publicado: (2023) -
CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling
por: Pu, Limeng, et al.
Publicado: (2022) -
Pocket2Drug: An Encoder-Decoder Deep Neural Network for the Target-Based Drug Design
por: Shi, Wentao, et al.
Publicado: (2022) -
GraphSite: Ligand Binding Site Classification with Deep Graph Learning
por: Shi, Wentao, et al.
Publicado: (2022) -
An integrated network representation of multiple cancer-specific data for graph-based machine learning
por: Pu, Limeng, et al.
Publicado: (2022)